Prospective analyses of survival of patients with indeterminate lesions and unequivocal metastatic disease at presentation in Bone & Soft tissue sarcoma across all ages of patients presenting to BST DMG, agnostic of the intent of treatment and site of metastasis or burden of disease - METSARC

Tata Memorial Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1. patient of any age/sex who presents with indeterminate lesions, or unequivocal radiological metastasis
•(including skip metastases), or biopsy proven synchronous metastatic disease in radiologically
•equivocal cases, at presentation, stratified for Ewing’s Sarcoma, Osteosarcoma (all subtypes),
•chondrosarcoma, Soft tissue sarcoma (round cell and NRSTS, including radiation induced sarcoma)
•irrespective of intent of treatment.
•2. Histopathological confirmation of primary sarcoma diagnosis at TMH
•3. Imaging review of standard of care staging investigations at TMH or documented radiology consensus
•at joint clinic appraisals for obvious metastases.
•4. Indeterminate lesions based off validated radiologic criteria and consensus in multi-disciplinary joint
•clinic (subcentimetre lesions, equivocal characteristics, minimal impact, not amenable to biopsy).

发起方